International Display Advertising Inc
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement… Read more
International Display Advertising Inc (IRME) - Net Assets
Latest net assets as of June 2025: $-625.00K USD
Based on the latest financial reports, International Display Advertising Inc (IRME) has net assets worth $-625.00K USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($175.00K) and total liabilities ($800.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-625.00K |
| % of Total Assets | -357.14% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 94.91 |
International Display Advertising Inc - Net Assets Trend (2020–2024)
This chart illustrates how International Display Advertising Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for International Display Advertising Inc (2020–2024)
The table below shows the annual net assets of International Display Advertising Inc from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-294.00K | -180.55% |
| 2023-12-31 | $365.00K | -85.92% |
| 2022-12-31 | $2.59 Million | +9.32% |
| 2021-12-31 | $2.37 Million | +69.24% |
| 2020-12-31 | $1.40 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to International Display Advertising Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1525800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $16.44 Million | % |
| Total Equity | $-294.00K | 100.00% |
International Display Advertising Inc Competitors by Market Cap
The table below lists competitors of International Display Advertising Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VGII11
SA:VGII11
|
$109.82K |
|
HUNTSMAN
MU:HTR
|
$109.82K |
|
CHARTWELL RETIREM.RESID.
F:6QD
|
$109.87K |
|
WeShop Holdings Limited Class A Ordinary Shares
NASDAQ:WSHP
|
$109.98K |
|
BCA POP. EMILIA R.
BE:4BE
|
$109.79K |
|
Dongwon Systems Corp. Pfd. Series 1
KQ:014825
|
$109.74K |
|
Rbr Top Offices Fundo De Investimento Imobiliario Responsabilidade Limitada
SA:TOPP11
|
$109.74K |
|
Scottish Mortgage Investment Trust PLC
PINK:STMZF
|
$109.63K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in International Display Advertising Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 365,000 to -294,000, a change of -659,000 (-180.5%).
- Net loss of 1,899,000 reduced equity.
- New share issuances of 755,000 increased equity.
- Other factors increased equity by 485,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.90 Million | -645.92% |
| Share Issuances | $755.00K | +256.8% |
| Other Changes | $485.00K | +164.97% |
| Total Change | $- | -180.55% |
Book Value vs Market Value Analysis
This analysis compares International Display Advertising Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.02 | $0.45 | x |
| 2021-12-31 | $0.04 | $0.45 | x |
| 2022-12-31 | $0.04 | $0.45 | x |
| 2023-12-31 | $0.01 | $0.45 | x |
| 2024-12-31 | $0.00 | $0.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently International Display Advertising Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-347.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -53.68% | 0.00% | 0.00x | 1.49x | $-892.10K |
| 2021 | -156.73% | 0.00% | 0.00x | 1.24x | $-3.95 Million |
| 2022 | -182.64% | 0.00% | 0.00x | 1.27x | $-4.99 Million |
| 2023 | -1344.93% | 0.00% | 0.00x | 2.74x | $-4.95 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.87 Million |
Industry Comparison
This section compares International Display Advertising Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| International Display Advertising Inc (IRME) | $-625.00K | -53.68% | N/A | $109.81K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |